Dr. Doucette, Dr. Dolinsky, and Dr. Hatch conducted a study to study the role of TAZ (Tafazzin), a cardiolipin (CL) biosynthetic enzyme important for maintaining mitochondrial function in regulating pancreatic islet function, particularly under low-glucose conditions.
CLICK HERE for the full article
What's New
All Articles
24-h ambulatory blood pressure readings and associations with albuminuria in youth with type 2 diabetes: A cross-sectional analysis from the iCARE cohort
24-hour ambulatory blood pressure monitors (ABPMs) are recommended for screening at risk children, however this test is not often used…
A new piece of the puzzle to explain how Type 1 Diabetes occurs and model the process in beta cells
A new study by CHRIM staff member and lead author Gabriel Brawerman in the lab of Dr. Peter Thompson has…
Tafazzin Deficiency Reduces Basal Insulin Secretion and Mitochondrial Function in Pancreatic Islets
Dr. Doucette, Dr. Dolinsky, and Dr. Hatch conducted a study to study the role of TAZ (Tafazzin), a cardiolipin (CL)…
Circadian Regulation of the Pancreatic Beta Cell
Dr. Doucette conducted a mini-review study where they have reviewed the recent literature that explores the importance of the pancreatic…
Beta cell therapies for type 1 diabetes
Dr. Thompson’s Lab published a study on different Beta Cells dysfunction and their respective therapeutic targets in preventing Type 1…
Prostaglandins and heart disease
Dr. Joe Gordon from our lab has published his recent study that highlights both the key historical studies that underpin…